We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Performance Measurements Standards Revisions Published for PET

By HospiMedica staff writers
Posted on 30 Jul 2007
A new performance measurement revision includes standards for positron emission tomography (PET), regardless of the scintillator used, and establishes methods of performance measurement on all currently available PET systems. More...
The new standards are more accurate at measuring scatter fraction and random coincidences than previous versions.

The U.S. National Electrical Manufacturers Association (NEMA; Rosslyn, VA, USA) recently published the revisions, called NEMA NU 2-2007 Performance Measurements of Positron Emission Tomographs. The major change since the last edition addresses an improvement in the inclusion of cameras with intrinsically radioactive components. Affected tests include count losses and randoms, as well as sensitivity. The spatial resolution measurement has been expanded to include the measurement and reporting of source position. Also, appendix A has been deleted.

According to Michael E. Casey, Ph.D., a member of the Coincidence Imaging Task Force chartered by the Nuclear Standards and Regulatory Committee, NEMA NU 2-2007 specifies methods that can be performed on all currently available PET scanners. "These include single and multiple slice, discrete and continuous detector, and time-of-flight instruments, as well as multi-planar and volume reconstruction models, dedicated PETs, and other coincidence-capable imaging systems. Wherever possible, future developments that could be readily anticipated were taken into account.”

The committee has not specified methods that may be especially appropriate for evaluating time-of-flight instruments, pending further evaluation of those instruments by the clinical and scientific communities. Dr. Casey reported that while this standard provides several advantages, it is the patient who gains the most. "A person undergoing a study benefits when a hospital or physician is able to compare tomographs from different manufactures to determine which best meets the needs of the patient,” he said.

When the first standard was developed in the early 1990s, PET was a research modality that focused chiefly on the brain. During the 1990s, the focus shifted to clinical applications with the discovery that PET was an excellent tool for imaging cancer. The revised NEMA NU 2-2007 follows this trend and takes these applications into account. The focus of the standard has changed to highlight whole-body imaging.

The contents and scope of NEMA NU 2-2007 Performance Measurements of Positron Emission Tomographs may be viewed, by visiting NEMA's website.

NEMA is an association geared for the electrical manufacturing industry.


Related Links:
NEMA

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.